Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor

Human Gene Therapy

Volumn 8, Issue 2, 1997, Pages 215-227

  Magovern, Christopher J ^a   Mack, Charles A ^a   Zhang, John ^a   Rosengart, Todd K ^a   Isom, O Wayne ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; VASCULOTROPIN;

ADENOVIRUS; ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; MALE; NONHUMAN; RAT;

EID: 0031039505     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.2-215     Document Type: Article

References (71)

1. ASAHARA, T., BAUTERS, C., ZHENG, L.P., TAKESHITA, S., BUNTING, S., FERRARA, N., SYMES, J.F., and ISNER, J.M. (1995). Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, II-365-II-371.
2. BANAI, S., JAKLITSCH, M.T., SHOU, M., LAZAROUS, D.F., SCHEINOWITZ, M., BIRO, S., EPSTEIN, S.E., and UNGER, E.F. (1994a). Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183-2189.
3. BANAI, S., SHWEIKI, D., PINSON, A., CHANDRA, M., LAZAROVICI, G., and KESHET, E. (1994b). Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc. Res. 28, 1176-1179.
4. BARR, E., CARROLL, J., KALYNYCH, A.M., TRIPATHY, S.K., KOZARSKY, K., and WILSON, J.M. (1994). Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1, 51-58.
5. BAUTERS, C., ASAHARA, T., ZHENG, L.P., TAKESHITA, S., BUNTING, S., FERRARA, N., SYMES, J.F., and ISNER, J.M. (1994). Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267, H1263-H1271.
6. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. BROGI, E., WU, T., NAMIKI, A., and ISNER, J.M. (1994). Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90, 649-652.
8. CHANG, M.W., BARR, E., SELTZER, J., JIANG, Y.Q., NABEL, G.J. NABEL, E.G., PARMACEK, M.S., and LEIDEN, J.M. (1995). Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267, 518-522.
9. CHARNOCK-JONES, D.S., SHARKEY, A.M., BOOCOCK, C.A., AHMED, A., PLEVIN, R., FERRARA, N., and SMITH, S.K. (1994). Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod. 51, 524-530.
10. CRYSTAL, R.G. (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404-410.
11. DE VRIES, C., ESCOBEDO, J.A., UENO, H., HOUCK, K., FERRARA, N., and WILLIAMS, L.T. (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-991.
12. DONG, J.Y., WANG, D.H., VANGINKEL, F.W., PASCUAL, D.W., and FRIZZELL, R.A. (1996). Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum. Gene Ther. 7, 319-331.
13. DVORAK, H.F., BROWN, L.F., DETMAR, M., and DVORAK, A.M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039.
14. EICHMANN, A., MARCELLE, C., BREANT, C., and LE DOUARIN, N.M. (1993). Two molecules related to the vegf receptor are expressed in early endothelial cells during avian embryonic development. Mech. Dev. 42, 33-48.
15. FERRARA, N., and HENZEL, W.J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851-858.
16. FERRARA, N., HOUCK, K.A., JAKEMAN, L.B., WINER, J., and LEUNG, D.W. (1991). The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211-218.
17. FERRARA, N., HOUCK, K., JAKEMAN, L., and LEUNG, D.W. (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol. Rev. 13, 18-32.
18. FERRARA, N., HEINSOHN, H., WALDER, C.E., BUNTING, S., and THOMAS, G.R. (1995). The regulation of blood vessel growth by vascular endothelial growth factor. Ann. NY Acad. Sci. 752, 246-256.
19. FOLKMAN, J., and SHING, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
20. FONG, G., ROSSANT, J., GERTSENSTEIN, M., and BREITMAN, M.L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-69.
21. FRENCH, B.A., MAZUR, W., ALI, N.M., GESKE, R.S., FINNIGAN, J.P., RODGERS, G.P., ROBERTS, R., and RAIZNER, A.E. (1994a). Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation 90, 2402-2413.
22. FRENCH, B.A., MAZUR, W., GESKE, R.S., and BOLLI, R. (1994b). Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 90, 2414-2424.
23. GILGENKRANTZ, H., DUBOC, D., JUILLARD, V., COUTON, D., PAVIRANI, A., GUILLET, J.G., BRIAND, P., and KHAN, A. (1995). Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response. Hum. Gene Ther. 6, 1265-1274.
24. GUZMAN, R.J., LEMARCHAND, P., CRYSTAL, R.G., EPSTEIN, S.E., and FINKEL, T. (1993a). Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation 88, 2838-2848.
25. GUZMAN, R.J., LEMARCHAND, P., CRYSTAL, R.G., EPSTEIN, S.E., and FINKEL, T. (1993b). Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ. Res. 73, 1202-1207.
26. GUZMAN, R.J., HIRSCHOWITZ, E.A., BRODY, S.L., CRYSTAL, R.G., EPSTEIN, S.E., and FINKEL, T. (1994). In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 91, 10732-10736.
27. HERSH, J., CRYSTAL, R.G., and BEWIG, B. (1995). Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2, 124-131.
28. HOUCK, K.A., LEUNG, D.W., ROWLAND, A.M., WINER, J., and FERRARA, N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031-26037.
29. HUDLICKA, O., and TYLER, K.R. (1986). Angiogenesis. The Growth of the Vascular System. (Academic Press, New York).
30. 165 in patient with ischaemic limb. Lancet 348, 370-374.
31. JAKEMAN, L.B., WINER, J., BENNETT, G.L., ALTAR, C.A., and FERRARA, N. (1992). Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J. Clin. Invest. 89, 244-253.
32. JAKEMAN, L.B., ARMANINI, M., PHILLIPS, H.S., and FERRARA, N. (1993). Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133, 848-859.
33. KAIPAINEN, A., KORHONEN, J., PAJUSOLA, K., APRELIKOVA, O., PERSICO, M.G., TERMAN, B.I., and ALITALO, K. (1993). The related flt4, flt1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 178, 2077-2088.
34. KASS-EISLER, A., FALCK-PEDERSEN, E., ALVIRA, M., RIVERA, J., BUTTRICK, P.M., WITTENBERG, B.A., CIPRIANI, L., and LEINWAND, L.A. (1993). Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc. Natl. Acad. Sci. USA 90, 11498-11502.
35. KASS-EISLER, A., LEINWAND, L.A., GALL, J., BLOOM, B., and FALCK-PEDERSEN, E. (1996). Circumventing the immune response to adenovirus mediated gene therapy. Gene Ther. 6, 154-162.
36. KECK, P.J., HAUSER, S.D., KRIVI, G., SANZO, K., WARREN, T., FEDER, J., and CONNOLLY, D.T. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-1312.
37. KOCH, A.B., HARLOW, L.A., HAINES, G.K., AMENTO, E.P., UNEMORI, E.N., WONG, W.L., POPE, R.M., and FERRARA, N. (1994). Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152, 4149-4156.
38. LEE, J., LAKS, H., DRINKWATER, D.C., BLITZ, A., CHANG, P., DRAKE, T.D., and ARDEHALI, A. (1996). Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. J. Thorac. Cardiovasc. Surg. 111, 246-252.
39. LEMARCHAND, P., JAFFE, H.A., DANEL, C., CID, M.C., KLEINMAN, H.K., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1992). Adenovirus-mediated transfer of a recombinant human alpha 1-anti-trypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA 89, 6482-6486.
40. LEMARCHAND, P., JONES, M., YAMADA, I., and CRYSTAL, R.G. (1993). In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ. Res. 72, 1132-1138.
41. LEMARCHAND, P., JONES, M., DANEL, C., YAMADA, I., MASTRANGELI, A., and CRYSTAL, R.G. (1994). In vivo adenovirus-mediated gene transfer to lungs via pulmonary artery. J. Appl. Physiol. 76, 2840-2845.
42. LEUNG, D.W., CACHIANES, G., KUANG, W.J., GOEDDEL, D.V., and FERRARA, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
43. LEVY, A.P., LEVY, N.S., LOSCALZO, J., CALDERONE, A., TAKAHASHI, N., YEO, K.T., KOREN, G., COLUCCI, W.S., and GOLDBERG, M.A. (1995). Regulation of vascular endothelial growth factor in cardiac myocytes. Circ. Res. 76, 758-766.
44. LI, J., BROWN, L.F., HIBBERD, M.G., GROSSMAN, J.D., and SIMONS, M. (1995). VEGF and VEGF receptors expression in acute myocardial infarction model of angiogenesis. Circulation 92:I-713(Abstract).
45. MASTRANGELI, A., DANEL, C., ROSENFELD, M.A., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1993). Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91, 225-234.
46. MASTRANGELI, A., HARVEY, B., YAO, J., WOLFF, G., KOVESDI, I., and CRYSTAL, R.G. (1996). "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum. Gene Ther. 1, 79-87.
47. MILLAUER, B., WIZIGMANN-VOOS, S., SCHNURCH, H., MARTINEZ, R., MOLLER, N.P., RISAU, W., and ULLRICH, A. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
48. 165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo. Circ. Res. 77, 1077-1086.
49. MÜHLHAUSER, J., JONES, M., YAMADA, I., CIRIELLI, C., LEMARCHAND, P., GLOE, T.R., BEWIG, B., SIGNORETTI, S., CRYSTAL, R.G., and CAPOGROSSI, M.C. (1996). Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 3, 145-153.
50. NABEL, E.G., POMPILI, V.J., PLAUTZ, G.E., and NABEL, G.J. (1994). Gene transfer and vascular disease. Cardiovasc. Res. 28, 445-455.
51. OHNO, T., GORDON, D., SAN, H., POMPILI, V.J., IMPERIALE, M.J., NABEL, G.J., and NABEL, E.G. (1994). Gene therapy for vascular smooth muscle cell proliferation after arterial injury [see comments]. Science 265, 781-784.
52. PARK, J.E., CHEN, H.H. WINER, J., HOUCK, K.A., and FERRARA, N. (1994). Placenta growth factor, potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to flt-1 but not to flk-1/kdr. J. Biol. Chem. 269, 25646-25654.
53. PEARLMAN, J.D., HIBBERD, M.G., CHUANG, M.L., HARADA, K., LOPEZ, J.J., GLADSTONE, S.R., FRIEDMAN, M., SELLKE, F.W., and SIMONS, M. (1995). Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1, 1085-1089.
54. PLATE, K.H., BREIER, G., MILLAUER, B., ULLRICH, A., and RISAU, W. (1993). Up-regulation of vascular endothlelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53, 5822-5827.
55. QIN, L., CHAVIN, K.D., DING, Y., FAVARO, J.P., WOODWARD, J.E., LIN, J., TAHARA, H., ROBBINS, P., SHARED, A., HO, D.Y., SAPOLSKY, R.M., LOTZE, M.T., and BROMBERG, J.S. (1995). Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with tgf-beta 1 or vil-10. Transplantation 59, 809-816.
56. ROME, J.J., SHAYANI, V., NEWMAN, K.D., FARRELL, S., LEE, S.W., VIRMANI, R., and DICHEK, D.A. (1994). Adenoviral vector-mediated gene transfer into sheep arteries using a double-balloon catheter. Hum. Gene Ther. 5, 1249-1258.
57. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J., and CYRSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
58. SEETHARAM, L., GOTOH, N., MARU, Y., NEUFELD, G., YAMAGUCHI, S., and SHIBUYA, M. (1995). A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10, 135-147.
59. SHALABY, F., ROSSANT, J., YAMAGUCHI, T.P., GERTSENSTEIN, M., WU, X.F., BREITMAN, M.L., and SCHUH, A.C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
60. STEG, P.G., FELDMAN, L.J., SCOAZEC, J.Y., TAHLIL, O., BARRY, J.J., BOULECHFAR, S., RAGOT, T., ISNER, J.M., and PERRICAUDET, M. (1994). Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circulation 90, 1648-1656.
61. TAKESHITA, S., PU, L.Q., STEIN, L.A., SNIDERMAN, A.D., BUNTING, S., FERRARA, N., ISNER, J.M., and SYMES, J.F. (1994a). Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90, I1228-I1234.
62. TAKESHITA, S., ZHENG, L.P., BROGI, E., KEARNEY, M., PU, L.Q., BUNTING, S., FERRARA, N., SYMES, J.F., and ISNER, J.M. (1994b). Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93, 662-670.
63. TAKESHITA, S., TSURUMI, Y., COUFFINAHL, T., ASAHARA, T., BAUTERS, C., SYMES, J., FERRARA, N., and ISNER, J.M. (1996). Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75, 487-501.
64. TERMAN, B.I., DOUGHER-VERMAZEN, M., CARRION, M.E., DIMITROV, D., ARMELLINO, D.C., GOSPODAROWICZ, D., and BOHLEN, P. (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187, 1579-1586.
65. TESSLER, S., ROCKWELL, P., HICKLIN, D., COHEN, T., LEVI, B.Z., WITTE, L., LEMISCHKA, I.R., and NEUFELD, G. (1994). Heparin modulates the interaction of VEGF165 with soluble and cell associated Flk-1 receptors. J. Biol. Chem. 269, 12456-12461.
66. TISCHER, E., GOSPODAROWICZ, D., MITCHELL, R., SILVA, M., SCHILLING, J., LAU, K., CRISP, T., FIDDES, J.C., and ABRAHAM, J.A. (1989). Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem. Biophys. Res. Commun. 165, 1198-1206.
67. TUDER, R.M., FLOOK, B.E., and VOELKEL N.F. (1995). Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95, 1798-1807.
68. WILLIAMS, S.K., WANG, T.F., CASTRILLO, R., and JARRELL, B.E. (1994). Liposuction-derived human fat used for vascular graft sodding contains endothelial cells and not mesothelial cells as the major cell type. J. Vasc. Surg. 19, 916-923.
69. YANG, R.H., THOMAS, G.R., BUNTING, S., KO, A., FERRARA, N., KEYT, B., ROSS, J., and JIN, H.K. (1996). Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J. Cardiovasc. Pharmacol. 27, 838-844.
70. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
71. YANG, Y., GREENOUGH, K., and WILSON, J.M. (1996). Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3, 412-420.